Develops oral drugs for type 1 diabetes.
Jun 2026Revenue $36.8M/yrExpenses $46.1M/yr
No trendCash runway ≈ 5.2 years from Jun 2026
Figures by year
When will vTv Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $36.8M and expenses $46.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $32.8M | −$32.8M |
| Dec 2024 | $1.02M | $25.2M | −$24.2M |
| Dec 2023 | $0.00 | $25.5M | −$25.5M |
| Dec 2022 | $2.02M | $24.6M | −$22.5M |
| Dec 2021 | $4.00M | $25.7M | −$21.7M |
| Dec 2020 | $6.41M | $18.3M | −$11.9M |
| Dec 2019 | $2.76M | $23.7M | −$20.9M |
| Dec 2018 | $12.4M | $32.3M | −$19.8M |
| Dec 2017 | $291K | $51.0M | −$50.7M |
| Dec 2016 | $634K | $55.7M | −$55.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.